Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Treatment with chemotherapy or radiation is not invariably cytotoxic to all tumor cells. Some of the cells that survive treatment recover and resume proliferation, whereas others undergo permanent growth arrest. To understand the nature of treatment-induced terminal growth arrest, colon carcinoma cells were exposed to doxorubicin, and surviving cells were separated into proliferating and growth-arrested populations. Only growth-arrested cells displayed phenotypic markers of cell senescence and failed to form colonies. Gene expression was compared between senescent and proliferating fractions of drug-treated cells by using cDNA microarray hybridization and reverse transcription–PCR. Drug-induced senescence was associated with inhibition of genes involved in cell proliferation and with coinduction of multiple intracellular and secreted growth inhibitors. Several tumor suppressors and other genes that are down-regulated in carcinogenesis were up-regulated in senescent tumor cells. Induction of most growth inhibitors was delayed but not abolished in cells with homozygous knockout of p53, in agreement with only limited p53 dependence of drug-induced terminal growth arrest. On the other hand, senescent cells overexpressed secreted proteins with antiapoptotic, mitogenic, and angiogenic activities, suggesting that drug-induced senescence is associated with paracrine tumor-promoting effects. About one-third of the genes up-regulated in senescent cells and almost all of the down-regulated genes showed decreased or delayed changes in p21 Waf1/Cip1/Sdi1 -deficient cells, indicating that p21 is a major mediator of the effects of p53 on gene expression. Elucidation of molecular changes in tumor cells that undergo drug-induced senescence suggests potential strategies for diagnostics and therapeutic modulation of this antiproliferative response in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many types of cytotoxic chemotherapies are severe DNA-damaging agents that can induce senescence in both tumor cells and surrounding normal cells (31–34).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Senescent cells acquire many changes in gene expression, mostly documented as altered mRNA abundance, including increased expression of secreted proteins [ 33 – 41 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Self-citationMitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Research works printed but not linked: 6
- B D Chang, E V Broude, M Dokmanovic, H Zhu, A Ruth, Y Xuan, E S Kandel, E Lausch, K Christov, I B Roninson Cancer Res 59, 3761–3767 (1999).
- J Campisi In Vivo (Athens, Greece) 14, 183–188 (2000).
- M A Jordan, K Wendell, S Gardiner, W B Derry, H Copp, L Wilson Cancer Res 56, 816–825 (1996).
- S K Myohanen, S B Baylin, J G Herman Cancer Res 58, 591–593 (1998).
- T Waldman, K W Kinzler, B Vogelstein Cancer Res 55, 5187–5190 (1995).
- Dotto, G. P. (2000) Biochim. Biophys. Acta 1471, M43-M56.
Cited by
Items 301–365 of 365
An RNA Signature Links Oxidative Stress To Cellular Senescence
Mullani, N. (2019) · theses.fr (ABES) · doi:10.70675/1babf95cz77a0z4561za6cdz6bf733f9f455
Rolle der Histonmethyltransferase Suv39h1 in zellulärer Seneszenz und Ras-induzierter Lymphomgenese
Braig, M. (2007) · edoc Publication server (Humboldt University of Berlin) · doi:10.18452/15698
An Overview of the Role of Senescence in Cancer
Al-Janabi, I. I. (2022) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v3i.77
CDK8 inhibitor: Senex's best thing
Haas, M. J. (2012) · Science-Business eXchange · doi:10.1038/scibx.2012.858
Crescenzi, E., Palumbo, G. A., de Boer, J., & Brady, H. J. M. (2023) · doi:10.1158/1078-0432.c.6518389
Boczek, U. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6890
Sarmento‐Ribeiro, A. B., Botelho, M. F., Gonçalves, A. C., Melo, J. B., Laranjo, M., Alves, R., Jorge, J., Ribeiro, I. P., Pires, S., Abrantes, A. M., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00026-4
Anti-Aging Medicine LiteratureWatch
(2002) · Rejuvenation Research · doi:10.1089/10945450260195658
Dornreiter, I. (2006) · PUBLISSO (German National Library of Medicine) · doi:10.4126/38m-002413460
Regulatory Mechanisms of Mitotic Catastrophe Induced by Doxorubicin
엄, 영. (2005) · AJOU Open Repository (Ajou University)
Cozzi, S., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2023) · doi:10.1158/0008-5472.c.6495171
Cozzi, S., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2023) · doi:10.1158/0008-5472.c.6495171.v1
Cozzi, S., Parsons, P. G., Ogbourne, S. M., Pedley, J., & Boyle, G. M. (2023) · doi:10.1158/0008-5472.22366509
Carr, S. D. (2013) · Repository@Hull (Worktribe) (University of Hull)
Data from Conditional Deletion of Insulin-like Growth Factor-I Receptor in Prostate Epithelium
Sutherland, B. W., Knoblaugh, S. E., Kaplan‐Lefko, P. J., Wang, F., Holzenberger, M., & Greenberg, N. M. (2023) · doi:10.1158/0008-5472.c.6497880
Suzuki, M., Suzuki, K., Yamashita, S., & Ta (2009) · Acta medica Nagasakiensia · doi:10.11343/amn.53.s51
Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine
Paola, A., & Barbagallo, M. (2007)
Tomascik-Cheeseman, L. (2003) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.1844
Александровна, П. Н., Vikhrova, S. Y., Korotkova, M. S., Kazansky, D. B., Tatarsky, V. V., & Zamkova, M. A. (2024) · Advances in molecular oncology · doi:10.17650/2313-805x-2024-11-1-90-98
Martinez-Rivera, M. (2016) · Digital Commons-TMC (Texas Medical Center)
Mapping the Radiogenome of Human Cancers
Gopal, P., Castrillon, J. A., & Abazeed, M. E. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_3
Kumari, R. (2019) · UCL Discovery (University College London)
Identifying Genes Responsible for Tamoxifen Resistance in Breast Cancer
Meijer, D. (2008) · RePub (Erasmus University Rotterdam)
Investigating the Biological Significance of Metallointercalators with cDNA Microarrays
Wright, E. P., Lyons, V. G., Wang, S., & Higgins, V. J. (2011) · Springer eBooks · doi:10.1007/978-3-211-99079-7_13
Study of the role of the cyclin-dependent kinase inhibitor p21Waf1/Cip1 in cellular senescence
Zapata-Bodalo, I. (2022) · theses.fr (ABES) · doi:10.70675/db01e49aza2daz4404za0f1za3db90231ce9
Chuma, M. (2016) · Springer eBooks · doi:10.1007/978-4-431-55852-1_13
Kou, M., Dan, M., Cheng, J., Ge, S., & Ren, R. (2026) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.70082
Strub, T. (2012) · theses.fr (ABES) · doi:10.70675/25b97242za449z4aa4za428z86c8bf3f6bd2
Coudereau, C. (2016) · theses.fr (ABES) · doi:10.70675/0c7c425ez5ad2z4596z97e5zcbd77b810a4d
Caractérisation des bases moléculaires et cellulaires de l'Entose.
Voisin, L. (2016) · theses.fr (ABES) · doi:10.70675/af514e7ez614cz455bz9817z8b3e15549b83
de Souza, L. M. (2014) · Americanae (AECID Library)
The role of miR-155-5p in the onset of senescence of Warton's Jelly Mesenchymal Stem Cells (WJ-MSCs)
Κυριακάκη, Σ. Ν., & Κυριακάκη, Σ. Ν. (2024) · University of Thessaly Institutional Repository (University of Thessaly)
Tumor-Immunzell-Interaktion und Seneszenz-assoziierte Moleküle im kolorektalen Karzinom
Kellers, F. (2023) · Gutenberg Open Science · doi:10.25358/openscience-9340
Implication du facteur de transcription E2F1 dans le mélanome
Rouaud, F. (2015) · theses.fr (ABES) · doi:10.70675/1a597f86zbdbaz4becz834dz2d86e55bfe60
Mersch, E. (2016) · DuEPublico (University of Duisburg-Essen)
Jonchère, B. (2014) · theses.fr (ABES) · doi:10.70675/8c18d191ze39dz4821z8452ze690f38af3d4
Effects of Creatine and Nicotinamide on experimentally induced senescence in dermal fibroblasts.
Mahajan, A. S. (2020) · OhioLink ETD Center (Ohio Library and Information Network)
Induction de la voie IFN/STAT1 dans le cancer du sein sous chimiothérapie : étude mécanistique
Gaston, J. (2016) · theses.fr (ABES) · doi:10.70675/f12f01b9z1813z4194z828cz931e4998f8d1
El-shaer, N. H., Eldeen, M. A., Hashem, A. M., Eid, R. A., & Raafat, N. (2021) · Systematic Reviews in Pharmacy · doi:10.31838/srp.2021.3.92
Leukocyte telomere attrition following radiotherapy in prostate cancer: a prospective study
Langsenlehner, T., Paal, K., Thurner, E.-M., Genser, S., Sternat, R., Stranz, B., & Renner, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-36205-x
TEX264-mediated selective autophagy in the repair of cytotoxic trapped PARP1
Hoslett, G. (2024) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-gpenzyedd
Cell senescence and aging in carcinogenesis and liver repopulation
Serra, M. P. (2012) · VEprints - Universita degli Studi di Cagliari
Effekter av bromerte flammehemmere på genekspresjon i muselever : en toksikogenomisk tilnærming
Landin, M. D. S. S. (2004) · NVA (Nasjonalt vitenarkiv)
IANNITTO, M. L. (2012) · IRIS Research product catalog (Sapienza University of Rome)
Therapy-induced stromal senescence promotes prostate cancer progression and aggressiveness
Pardella, E. (2021) · Use Siena air (University of Siena) · doi:10.25434/pardella-elisa_phd2021
Cambios metabólicos asociados a la senescencia del melanoma
Martínez, J. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The effects of genotoxic stress on the p53/p21wafl/cip1 response
Bodzak, E. (2004) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/16478
Selektivität der p53-Antwort auf genotoxischen Streß
Speidel, D. (2004) · Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) · doi:10.15488/6461
Basoli, V. (2017) · UnissResearch (Università degli Studi di Sassari)
The impact of MAO-A in cellular senescence
Sequeiros, P. E. D. M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Scheitenberger, M. L. (2015) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-4664
(n.d.) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
1á,25(OH)2-VITAMIN D3 IN PROSTATE: INTERSECTION WITH AKT/PTEN AXIS AND ROLE IN SENESCENCE
Axanova, L. S. (2010) · WakeSpace Scholarship (Wake Forest University)
Mersch, E. (2016) · DuEPublico (University of Duisburg-Essen)
Durán, M. L. (2016) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Zander, T., Schultze, J. L., Pillai, R., & Debey, S. (2005) · Informa Healthcare eBooks · doi:10.1201/9781420038095.sec2
Cheung, V. G. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1014162.192881
Metadata
- Authors
- Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Roninson, Igor B.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 99
- Issue
- 1
- Pages
- 389-394
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117570
- OpenAlex
- W2162118018
- Cited by
- 312
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 13 · 2012: 16
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37ca040333-15)
- National Cancer Institute (R37 CA 40333, R01CA089636, R01CA062099)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK0773909)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- drug-induced senescence, doxorubicin, colon cancer cells, p53, tumor suppressor, growth inhibitors, anti-apoptotic factors, angiogenic factors, chemoresistance, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Division, Doxorubicin, Humans, Neoplasms, Phenotype, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Down-Regulation, Up-Regulation, Genes, p53, Proto-Oncogene Proteins p21(ras), Cellular Senescence, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.